Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.310
+0.300 (14.93%)
At close: Nov 22, 2024, 4:00 PM
2.340
+0.030 (1.30%)
After-hours: Nov 22, 2024, 6:39 PM EST
Inhibikase Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Cash & Equivalents | 0.91 | 9.17 | 7.19 | 40.75 | 13.95 | 0.02 | Upgrade
|
| Short-Term Investments | 2.33 | 4.09 | 15.86 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 3.24 | 13.25 | 23.05 | 40.75 | 13.95 | 0.02 | Upgrade
|
| Cash Growth | -80.73% | -42.51% | -43.44% | 192.04% | 75500.11% | -95.14% | Upgrade
|
| Receivables | - | - | 0.04 | 0.11 | - | - | Upgrade
|
| Prepaid Expenses | 0.39 | 0.93 | 1.28 | 1.61 | 0.83 | 0.02 | Upgrade
|
| Other Current Assets | 0.55 | 0.03 | - | - | - | - | Upgrade
|
| Total Current Assets | 4.19 | 14.21 | 24.37 | 42.47 | 14.78 | 0.04 | Upgrade
|
| Property, Plant & Equipment | 0.19 | 0.3 | 0.57 | - | - | - | Upgrade
|
| Long-Term Deferred Charges | - | - | - | - | - | 0 | Upgrade
|
| Total Assets | 4.38 | 14.51 | 24.94 | 42.47 | 14.78 | 0.04 | Upgrade
|
| Accounts Payable | 2.53 | 0.65 | 1.15 | 1.09 | 1.72 | 1 | Upgrade
|
| Accrued Expenses | 2.16 | 2.26 | 2.4 | 2.72 | 0.63 | 1.72 | Upgrade
|
| Short-Term Debt | 0.07 | 0.38 | - | - | 0.04 | 0.1 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 0.25 | - | - | Upgrade
|
| Current Portion of Leases | 0.15 | 0.15 | 0.15 | - | - | - | Upgrade
|
| Current Unearned Revenue | - | - | - | - | 2.33 | 1.43 | Upgrade
|
| Total Current Liabilities | 4.91 | 3.44 | 3.7 | 4.05 | 4.72 | 4.25 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.28 | 0.28 | Upgrade
|
| Long-Term Leases | - | 0.09 | 0.21 | - | - | - | Upgrade
|
| Total Liabilities | 4.91 | 3.53 | 3.9 | 4.05 | 5 | 4.53 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0 | 0.03 | 0.01 | 0.01 | Upgrade
|
| Additional Paid-In Capital | 81.75 | 77.87 | 68.8 | 68.21 | 24.81 | 7.69 | Upgrade
|
| Retained Earnings | -82.29 | -66.9 | -47.87 | -29.82 | -15.03 | -12.18 | Upgrade
|
| Comprehensive Income & Other | 0 | 0 | 0.1 | - | - | - | Upgrade
|
| Shareholders' Equity | -0.53 | 10.98 | 21.04 | 38.42 | 9.78 | -4.49 | Upgrade
|
| Total Liabilities & Equity | 4.38 | 14.51 | 24.94 | 42.47 | 14.78 | 0.04 | Upgrade
|
| Total Debt | 0.22 | 0.62 | 0.35 | 0.25 | 0.32 | 0.37 | Upgrade
|
| Net Cash (Debt) | 3.03 | 12.63 | 22.7 | 40.5 | 13.63 | -0.36 | Upgrade
|
| Net Cash Growth | -81.72% | -44.36% | -43.96% | 197.05% | - | - | Upgrade
|
| Net Cash Per Share | 0.46 | 2.37 | 5.37 | 13.35 | 9.96 | -0.26 | Upgrade
|
| Filing Date Shares Outstanding | 67.19 | 6.48 | 4.83 | 4.2 | 1.68 | 1.36 | Upgrade
|
| Total Common Shares Outstanding | 7.46 | 6.19 | 4.2 | 4.19 | 1.68 | 1.36 | Upgrade
|
| Working Capital | -0.72 | 10.77 | 20.68 | 38.42 | 10.06 | -4.22 | Upgrade
|
| Book Value Per Share | -0.07 | 1.77 | 5.00 | 9.16 | 5.84 | -3.29 | Upgrade
|
| Tangible Book Value | -0.53 | 10.98 | 21.04 | 38.42 | 9.78 | -4.49 | Upgrade
|
| Tangible Book Value Per Share | -0.07 | 1.77 | 5.00 | 9.16 | 5.84 | -3.29 | Upgrade
|
| Machinery | - | 0.1 | 0.24 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.